Browsing Tag
Horizon Pharma Therapeutics
1 post
Lupin launches authorized generic of PENNSAID in US to tap $509m osteoarthritis knee pain market
Lupin launches the authorized generic of PENNSAID in the U.S., targeting the $509M osteoarthritis knee pain market with a proven, cost-effective NSAID solution.